IMAPRB - INVERNESS MED INNOVATIONS IN PFD CONV SER B
This page shows which of the focused investors we track hold IMAPRB and how their positions changed, so you can see how much conviction the group has in the stock.
In Q1 2010 it was held by 2 managers with an aggregate reported value of $54.17M, which is 0.00% of the combined portfolio.
As of Q1 2010, 2 tracked institutional managers held IMAPRB (INVERNESS MED INNOVATIONS IN PFD CONV SER B) with an aggregate reported value of $54.17M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades IMAPRB — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q1 2010
- Ticker
- IMAPRB
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Howard Marks - Oaktree Capital Management | 0.75% | New | 157,231 | $41.43M |
| 2 | ValueAct Capital - ValueAct Capital | 0.45% | Add +1.1% | 47,722 | $12.74M |
Loading holder history for IMAPRB…